Aster DM Healthcare reported a strong set of March-quarter earnings, with net profit rising 45 percent year-on-year to ₹153 crore, driven by higher patient volumes and improved operating margins.
Revenue from operations grew 18 percent to around ₹1,182 crore, reflecting steady demand across hospitals, clinics and diagnostics segments.
The company’s performance was supported by increased occupancy levels and a rise in patient footfall across key markets. Operating leverage, along with cost discipline, helped expand margins during the quarter.
Operating EBITDA rose sharply during the quarter, aided by better realisations and efficiency improvements across its network.
Aster’s India-focused strategy continues to deliver results, with hospitals remaining the key growth engine. The company has been strengthening its presence in core clusters such as Kerala, Karnataka and Maharashtra, where demand for healthcare services remains robust.
The proposed merger with Quality Care India Ltd (QCIL) has received strong shareholder approval of over 96 percent, positioning the combined entity as a major hospital network in the country.
